(sphingotec GmbH) Sphingotec reports study data demonstrating that its proprietary renal function biomarker penKid® (Proenkephalin) predicts acute kidney injury (AKI), multi-organ failure and mortality in sepsis patients presenting to the emergency department (ED).

Original source: https://www.eurekalert.org/pub_releases/2019-12/sg-sbp122019.php